Goldshield is a global Pharmaceutical company, headquartered in the UK and listed on the London Stock Exchange.  The company  also has offices in the US and India and has achieved rapid growth both organically and through astute product acquisitions.

Goldshield has a professional team with knowledge and experience in the following areas; Acquisitions, integration of acquisitions, in-licensing, developing and implanting growth strategies, marketing products and distributor management.

The company is dedicated to ensuring success and building strong relationships with customers and suppliers, which means that it is well positioned to partner with other companies to successfully commercialize products in a wide range of therapeutic areas and market settings. The key therapy areas of interest would be:  Cardiology, Urology, dermatology and Ophthalmology.

Goldshield has an extensive distributor base and distribution channels which cover more than 60 countries, access to a wide customer base of pharmacies, hospitals and doctors and an established worldwide network of manufacturing partners which it has built over the last 15 years.

Goldshield aims to continue to grow through the following:

•    Acquisition (strategic alliances)
•    Specialized product development
•    In-licensing

The company is interested in hearing from companies who can offer any opportunities in these areas.